Filed: 2/14/2024ACC: 0001012975-24-000103
📋 What this filing means
NEA MANAGEMENT COMPANY, LLC filed this quarterly 13F‑HR report disclosing 44 equity positions with a total reported market value of $1.50B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
44
Positions
$1.50B
Total AUM (reported)
290.05M
Total Shares
Allocation by class
COM$926.73M61.8%
COMMON STOCK$245.59M16.4%
SPONSERED ADS$122.37M8.2%
NAMEN AKT$99.40M6.6%
COM NEW$50.28M3.4%
COM SER A$18.78M1.3%
SPONDS ADR$13.54M0.9%
Portfolio Concentration
Top 3$590.88M39.4%
4–10$532.63M35.5%
11–25$282.59M18.8%
Rest$94.34M6.3%
Top 3 weight
39.4%
Top 10 weight
74.9%
Voting Authority Distribution
Total shares with voting rights: 290.05M
Sole
Full voting authority
290.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other44
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings44
Rows:
COURSERA INC
DFNDShares12.87M
TypeSH
Market value$249.25M
16.61%
Sole
12.87M
Shared
0.00
None
0.00
ARCELLX INC
DFNDShares3.75M
TypeSH
Market value$207.86M
13.85%
Sole
3.75M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
DFNDShares2.91M
TypeSH
Market value$133.77M
8.92%
Sole
2.91M
Shared
0.00
None
0.00
SAVARA INC
DFNDShares24.47M
TypeSH
Market value$115.01M
7.67%
Sole
24.47M
Shared
0.00
None
0.00
VERONA PHARMA PLC
DFNDShares5.11M
TypeSH
Market value$111.02M
7.40%
Sole
5.11M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
DFNDShares1.59M
TypeSH
Market value$99.40M
6.62%
Sole
1.59M
Shared
0.00
None
0.00
CVRX INC
DFNDShares2.37M
TypeSH
Market value$74.53M
4.97%
Sole
2.37M
Shared
0.00
None
0.00
GERON CORP
DFNDShares22.78M
TypeSH
Market value$48.06M
3.20%
Sole
22.78M
Shared
0.00
None
0.00
MONTE ROSA THERAPEUTICS INC
DFNDShares7.69M
TypeSH
Market value$43.46M
2.90%
Sole
7.69M
Shared
0.00
None
0.00
KORRO BIO INC
DFNDShares1.07M
TypeSH
Market value$41.14M
2.74%
Sole
1.07M
Shared
0.00
None
0.00
NEXTNAV INC
DFNDShares8.19M
TypeSH
Market value$36.44M
2.43%
Sole
8.19M
Shared
0.00
None
0.00
AURINIA PHARMACEUTICALS INC
DFNDShares3.97M
TypeSH
Market value$35.69M
2.38%
Sole
3.97M
Shared
0.00
None
0.00
NKARTA INC
DFNDShares3.57M
TypeSH
Market value$23.55M
1.57%
Sole
3.57M
Shared
0.00
None
0.00
BRIGHT HEALTH GROUP INC
DFNDShares2.73M
TypeSH
Market value$19.86M
1.32%
Sole
2.73M
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
DFNDShares3.85M
TypeSH
Market value$18.78M
1.25%
Sole
3.85M
Shared
0.00
None
0.00
CELCUITY INC
DFNDShares1.25M
TypeSH
Market value$18.21M
1.21%
Sole
1.25M
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
DFNDShares1.96M
TypeSH
Market value$17.90M
1.19%
Sole
1.96M
Shared
0.00
None
0.00
ALLAKOS INC
DFNDShares6.15M
TypeSH
Market value$16.78M
1.12%
Sole
6.15M
Shared
0.00
None
0.00
ZEROFOX HLDGS INC
DFNDShares18.07M
TypeSH
Market value$15.72M
1.05%
Sole
18.07M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
DFNDShares11.37M
TypeSH
Market value$15.24M
1.02%
Sole
11.37M
Shared
0.00
None
0.00
GOSSAMER BIO INC
DFNDShares15.84M
TypeSH
Market value$14.45M
0.96%
Sole
15.84M
Shared
0.00
None
0.00
ADAPTIMMUNE THERAPEUTICS PLC
DFNDShares17.08M
TypeSH
Market value$13.54M
0.90%
Sole
17.08M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
DFNDShares14.99M
TypeSH
Market value$12.57M
0.84%
Sole
14.99M
Shared
0.00
None
0.00
BLACK DIAMOND THERAPEUTICS INC
DFNDShares4.45M
TypeSH
Market value$12.50M
0.83%
Sole
4.45M
Shared
0.00
None
0.00
TUYA INC
DFNDShares4.93M
TypeSH
Market value$11.35M
0.76%
Sole
4.93M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
COURSERA INCDFND | COM | 12.87M | SH | $249.25M 16.61% | 12.87M | 0.00 | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 3.75M | SH | $207.86M 13.85% | 3.75M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCDFND | COM | 2.91M | SH | $133.77M 8.92% | 2.91M | 0.00 | 0.00 |
SAVARA INCDFND | COM | 24.47M | SH | $115.01M 7.67% | 24.47M | 0.00 | 0.00 |
VERONA PHARMA PLCDFND | SPONSERED ADS | 5.11M | SH | $111.02M 7.40% | 5.11M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGDFND | NAMEN AKT | 1.59M | SH | $99.40M 6.62% | 1.59M | 0.00 | 0.00 |
CVRX INCDFND | COM | 2.37M | SH | $74.53M 4.97% | 2.37M | 0.00 | 0.00 |
GERON CORPDFND | COM | 22.78M | SH | $48.06M 3.20% | 22.78M | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCDFND | COM | 7.69M | SH | $43.46M 2.90% | 7.69M | 0.00 | 0.00 |
KORRO BIO INCDFND | COM | 1.07M | SH | $41.14M 2.74% | 1.07M | 0.00 | 0.00 |
NEXTNAV INCDFND | COMMON STOCK | 8.19M | SH | $36.44M 2.43% | 8.19M | 0.00 | 0.00 |
AURINIA PHARMACEUTICALS INCDFND | COM | 3.97M | SH | $35.69M 2.38% | 3.97M | 0.00 | 0.00 |
NKARTA INCDFND | COM | 3.57M | SH | $23.55M 1.57% | 3.57M | 0.00 | 0.00 |
BRIGHT HEALTH GROUP INCDFND | COM NEW | 2.73M | SH | $19.86M 1.32% | 2.73M | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCDFND | COM SER A | 3.85M | SH | $18.78M 1.25% | 3.85M | 0.00 | 0.00 |
CELCUITY INCDFND | COM | 1.25M | SH | $18.21M 1.21% | 1.25M | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCDFND | COM | 1.96M | SH | $17.90M 1.19% | 1.96M | 0.00 | 0.00 |
ALLAKOS INCDFND | COM | 6.15M | SH | $16.78M 1.12% | 6.15M | 0.00 | 0.00 |
ZEROFOX HLDGS INCDFND | COM | 18.07M | SH | $15.72M 1.05% | 18.07M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCDFND | COM | 11.37M | SH | $15.24M 1.02% | 11.37M | 0.00 | 0.00 |
GOSSAMER BIO INCDFND | COM | 15.84M | SH | $14.45M 0.96% | 15.84M | 0.00 | 0.00 |
ADAPTIMMUNE THERAPEUTICS PLCDFND | SPONDS ADR | 17.08M | SH | $13.54M 0.90% | 17.08M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCDFND | COM | 14.99M | SH | $12.57M 0.84% | 14.99M | 0.00 | 0.00 |
BLACK DIAMOND THERAPEUTICS INCDFND | COM | 4.45M | SH | $12.50M 0.83% | 4.45M | 0.00 | 0.00 |
TUYA INCDFND | SPONSERED ADS | 4.93M | SH | $11.35M 0.76% | 4.93M | 0.00 | 0.00 |
Page 1 of 2